Europe - Euronext Paris - EPA:VIRP - FR0000031577 - Common Stock
Overall VIRP gets a fundamental rating of 5 out of 10. We evaluated VIRP against 55 industry peers in the Pharmaceuticals industry. VIRP has an average financial health and profitability rating. VIRP is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8% | ||
| ROE | 13.64% | ||
| ROIC | 11.47% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.39% | ||
| PM (TTM) | 10.4% | ||
| GM | 67.1% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 3.62 | ||
| Altman-Z | 4.78 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.04 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.65 | ||
| Fwd PE | 16.84 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 33.45 | ||
| EV/EBITDA | 11.1 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.4% |
ChartMill assigns a fundamental rating of 5 / 10 to VIRP.PA.
ChartMill assigns a valuation rating of 4 / 10 to VIRBAC SA (VIRP.PA). This can be considered as Fairly Valued.
VIRBAC SA (VIRP.PA) has a profitability rating of 6 / 10.
The financial health rating of VIRBAC SA (VIRP.PA) is 6 / 10.
The Earnings per Share (EPS) of VIRBAC SA (VIRP.PA) is expected to grow by 3.92% in the next year.